What is the diagnosis and treatment for Suppurative Hydronephrosis (inflammation of the kidney due to urine flow obstruction)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Hydronitis suppurative, also known as pyonephrosis, is a life-threatening condition that requires immediate urinary tract decompression, which can be achieved through percutaneous nephrostomy (PCN) or retrograde ureteral catheterization, with PCN being the preferred method in unstable patients or those with multiple comorbidities. The decision to perform PCN depends on clinical symptoms of sepsis, and recent data suggest that serum C-reactive protein may be a useful parameter in making this decision 1.

In patients with pyonephrosis, PCN is usually technically successful and results in marked clinical improvement, yielding important bacteriological information and altering antibiotic treatment regimens 1. A recent study demonstrated the superiority of third-generation cephalosporin ceftazidime versus fluoroquinolone ciprofloxacin in both clinical and microbiological cure rates, with improved early and long-term cure rates in those who received PCN versus ureteral stent 1.

Key considerations in the management of hydronitis suppurative include:

  • Emergent drainage with PCN or retrograde ureteral catheterization in unstable patients or those with multiple comorbidities
  • Use of preprocedural antibiotics when urosepsis is suspected or known to be present
  • Monitoring for postprocedural bacteremia and sepsis
  • Consideration of third-generation cephalosporin ceftazidime as the preferred antibiotic regimen

The use of PCN in neonatal renal candidiasis has also been shown to be valuable in eradicating funguria and is an attractive alternative to surgical decompression 1. In contrast, retrograde ureteral stenting is also a viable option, particularly in patients with obstructive pyelonephritis/pyonephrosis, and can be used in conjunction with antibiotic therapy as a first-line treatment option 1.

Overall, the management of hydronitis suppurative should prioritize PCN as the primary method of urinary tract decompression, with careful consideration of antibiotic regimens and monitoring for potential complications.

From the Research

Definition and Diagnosis of Hydronitis Supperative

  • Hydronitis supperative, also known as suppurative pyelonephritis, is a severe infection of the kidney that can lead to the formation of pus and abscesses 2.
  • The diagnosis of suppurative pyelonephritis is typically made based on a combination of clinical symptoms, laboratory tests, and imaging studies, such as computed tomography (CT) scans 3.

Risk Factors and Complications

  • Certain risk factors, such as old age, male sex, deranged renal function, and presence of disseminated intravascular coagulation, are associated with an increased risk of mortality from suppurative pyelonephritis 2.
  • Patients with suppurative pyelonephritis are at risk of developing severe complications, including sepsis, shock, and multiorgan failure 2, 3.

Treatment Options

  • Treatment options for suppurative pyelonephritis include antibiotic therapy, drainage of abscesses, and surgical intervention, such as nephrectomy 2, 3.
  • In severe cases, immediate nephrectomy may be necessary to prevent further complications and improve outcomes 3.
  • The choice of treatment depends on the severity of the infection, the presence of underlying medical conditions, and the patient's overall health status 4.

Importance of Early Recognition and Treatment

  • Early recognition and treatment of suppurative pyelonephritis are critical to limiting morbidity and preventing serious complications 4, 5.
  • Delayed treatment can lead to increased risk of mortality and long-term kidney damage 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Severe acute pyelonephritis: a review of clinical outcome and risk factors for mortality.

Hong Kong medical journal = Xianggang yi xue za zhi, 2014

Research

Acute Pyelonephritis in Adults: Rapid Evidence Review.

American family physician, 2020

Research

Acute pyelonephritis: risk factors, diagnosis and treatment.

Nursing standard (Royal College of Nursing (Great Britain) : 1987), 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.